Literature DB >> 10713688

Mutant p53 and genomic instability in a transgenic mouse model of breast cancer.

K L Murphy1, J M Rosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10713688     DOI： 10.1038/sj.onc.1203274

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  8 in total

1.  p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.

Authors:  Catherine A Vaughan; Shilpa Singh; Brad Windle; Heidi M Sankala; Paul R Graves; W Andrew Yeudall; Swati P Deb; Sumitra Deb
Journal:  Arch Biochem Biophys       Date:  2011-12-16       Impact factor: 4.013

Review 2.  Centrosome amplification and the origin of chromosomal instability in breast cancer.

Authors:  Jeffrey L Salisbury; Antonino B D'Assoro; Wilma L Lingle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

Review 3.  Animal models of breast cancer for the study of pathogenesis and therapeutic insights.

Authors:  Angels Sierra
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

4.  Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants.

Authors:  Anja Restle; Martin Färber; Cindy Baumann; Michael Böhringer; Karl Heinz Scheidtmann; Carsten Müller-Tidow; Lisa Wiesmüller
Journal:  Nucleic Acids Res       Date:  2008-08-12       Impact factor: 16.971

5.  Essential role for centromeric factors following p53 loss and oncogenic transformation.

Authors:  Dan Filipescu; Monica Naughtin; Katrina Podsypanina; Vincent Lejour; Laurence Wilson; Zachary A Gurard-Levin; Guillermo A Orsi; Iva Simeonova; Eleonore Toufektchan; Laura D Attardi; Franck Toledo; Geneviève Almouzni
Journal:  Genes Dev       Date:  2017-03-29       Impact factor: 11.361

Review 6.  Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?

Authors:  Anneke C Blackburn; D Joseph Jerry
Journal:  Breast Cancer Res       Date:  2002-04-18       Impact factor: 6.466

7.  The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer.

Authors:  Stefania Pizzimenti; Cristina Toaldo; Piergiorgio Pettazzoni; Mario U Dianzani; Giuseppina Barrera
Journal:  Cancers (Basel)       Date:  2010-03-30       Impact factor: 6.639

8.  Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.

Authors:  Adam D Pfefferle; Yash N Agrawal; Daniel C Koboldt; Krishna L Kanchi; Jason I Herschkowitz; Elaine R Mardis; Jeffrey M Rosen; Charles M Perou
Journal:  Dis Model Mech       Date:  2016-05-05       Impact factor: 5.758
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.